Tucaresol Analog-Based Sensing and Diagnostic Systems
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of tucaresol and its analogs to develop novel sensing and diagnostic systems for diverse industries, including environmental monitoring, food safety, personal care, neurodegenerative disease diagnosis, and agricultural crop management.
Background and Problem Solved
The original patent focused on tucaresol and its analogs in pharmaceutical compositions for treating human cancers. However, the unique properties of these compounds also make them suitable for various non-pharmaceutical applications. The new inventive concept addresses the need for innovative sensing and diagnostic solutions in multiple fields, where the selective binding properties of tucaresol analogs can provide a competitive advantage.
Detailed Description of the Inventive Concept
The new inventive concept encompasses systems and methods utilizing tucaresol analogs as sensing agents, diagnostic markers, or antimicrobial agents. In environmental monitoring, these compounds can selectively bind to target pollutants, enabling accurate quantification. In food safety, tucaresol analogs can detect foodborne pathogens, ensuring rapid and reliable identification. In personal care, the antimicrobial properties of these compounds can be harnessed to target specific microbial populations on the skin. In neurodegenerative disease diagnosis, tucaresol analogs can serve as diagnostic markers, facilitating early detection and treatment. Lastly, in agricultural crop management, these compounds can selectively control the growth of target pests or weeds.
Novelty and Inventive Step
The new inventive concept is novel and non-obvious as it applies the core technology of tucaresol and its analogs to entirely different industries and use cases, leveraging the compounds' unique properties to address specific problems in each field. The inventive step lies in the recognition of the potential of these compounds beyond pharmaceutical applications and the development of innovative systems and methods to harness their capabilities.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include the use of tucaresol analogs in combination with other sensing agents or diagnostic markers, the development of portable or handheld detection devices, or the integration of these systems with existing technologies in each industry. Variations may also include the design of tucaresol analogs with specific functional groups to enhance their sensing or diagnostic capabilities.
Potential Commercial Applications and Market
The tucaresol analog-based sensing and diagnostic systems have significant commercial potential across multiple industries, including environmental monitoring, food safety, personal care, neurodegenerative disease diagnosis, and agricultural crop management. The market for these innovative solutions is substantial, driven by growing demands for accurate detection, efficient diagnosis, and targeted treatment in each of these fields.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/192 |
| A | A61 | A61K31/496 |
| A | A61 | A61K39/3955 |
| A | A61 | A61P35/00 |
| C | C07 | C07K16/2818 |
| C | C07 | C07K16/2827 |
| A | A61 | A61K2039/505 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medicinal chemistry and biotechnology, with expertise in compound design, diagnostic systems, and pharmaceutical applications involving immune system modulation and targeted molecular interactions
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degree in chemistry or biochemistry, experienced in designing molecular compounds, understanding structure-function relationships, and applying chemical analogs across multiple technological domains
Obviousness Rationale
A PHOSITA would recognize that the tucaresol analog's core structural properties enable versatile applications beyond the original pharmaceutical context. The compound's inherent molecular characteristics naturally suggest potential sensing and diagnostic uses across different industries. The PTD represents a predictable extension of the source patent's foundational molecular technology by leveraging known chemical interaction principles.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,522 |
|---|---|
| Title | Compositions containing tucaresol or its analogs |
| Assignee(s) | BeyondSpring Pharmaceuticals, Inc. |